Kestra Advisory Services, LLC Abb Vie Inc. Transaction History

Kestra Advisory Services, LLC

$14.4 Billion
Q1 2024

A detailed history of Kestra Advisory Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 306,105 shares of ABBV stock, worth $52.5 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

306,105

Previous 289,111 5.88%

Holding current value

$52.5 Million

Previous $44.8 Million 24.41%

% of portfolio

0.39%

Previous 0.38%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $2.72 Million - $3.09 Million	16,994 Added 5.88%	306,105 $55.7 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $820,371 - $923,931	5,962 Added 2.11%	289,111 $44.8 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $7.2 Million - $8.33 Million	-53,877 Reduced 15.99%	283,149 $42.2 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $5.5 Million - $6.84 Million	41,499 Added 14.04%	337,026 $45.4 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $8.8 Million - $10.1 Million	-60,875 Reduced 17.08%	295,527 $47.1 Million

Q4 2022 Jan 31, 2023	SELL	$138.31 - $165.87 $216,178 - $259,254	-1,563 Reduced 0.44%	356,402 $57.6 Million
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $9.35 Million - $10.7 Million	69,687 Added 24.17%	357,965 $48 Billion
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $2.18 Million - $2.77 Million	15,852 Added 5.82%	288,278 $44.2 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $7.43 Million - $9.22 Million	-56,292 Reduced 17.12%	272,426 $44.2 Million
Q4 2021 Jan 20, 2022	SELL	$107.43 - $135.93 $733,532 - $928,130	-6,828 Reduced 2.03%	328,718 $44.5 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $2.61 Million - $2.96 Million	24,493 Added 7.87%	335,546 $36.2 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $569,291 - $634,223	5,411 Added 1.77%	311,053 $35 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $796,405 - $876,746	7,785 Added 2.61%	305,642 $33.1 Million
Q4 2020 Jan 20, 2021	BUY	$80.49 - $108.67 $5.28 Million - $7.12 Million	65,546 Added 28.21%	297,857 $31.4 Billion
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $20 Million - $23.4 Million	232,311 New	232,311 $20.4 Billion

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Abb Vie Inc. Transaction History